Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites

Clinical trial NCT05303844 · UNKNOWN

Trial details

NCT number: NCT05303844
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Malignant Ascites

Start date: 2022-04-02
Primary completion: 2025-03-20
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.